306 related articles for article (PubMed ID: 23979521)
1. Clonal evolution in hematological malignancies and therapeutic implications.
Landau DA; Carter SL; Getz G; Wu CJ
Leukemia; 2014 Jan; 28(1):34-43. PubMed ID: 23979521
[TBL] [Abstract][Full Text] [Related]
2. Multiomics of three hematological malignancies in a patient reveal their origin from clonal hematopoietic stem cells.
Mayeur S; Molitor A; Miguet L; Rigolot L; Naegely L; Stemmelen T; Meyer S; Toussaint E; Vallat L; Eischen A; Chenard MP; Tavian M; Bahram S; Carapito R; Nicolae A
Blood Cancer J; 2023 Aug; 13(1):118. PubMed ID: 37558702
[No Abstract] [Full Text] [Related]
3. Cell Culture and Slide Preparation for Cytogenetic Studies of Hematological Neoplasms.
Yu J
Methods Mol Biol; 2024; 2825():127-135. PubMed ID: 38913306
[TBL] [Abstract][Full Text] [Related]
4. Functionalized Lineage Tracing Can Enable the Development of Homogenization-Based Therapeutic Strategies in Cancer.
Gutierrez C; Vilas CK; Wu CJ; Al'Khafaji AM
Front Immunol; 2022; 13():859032. PubMed ID: 35603167
[TBL] [Abstract][Full Text] [Related]
5. Editorial: The progress and challenges of hematological malignancies in the era of big data and new therapy.
Hu H
Cancer Lett; 2023 Oct; 575():216399. PubMed ID: 37741432
[No Abstract] [Full Text] [Related]
6. Toward a systems-level probing of tumor clonality.
Grody EI; Abraham A; Shukla V; Goyal Y
iScience; 2023 May; 26(5):106574. PubMed ID: 37192968
[TBL] [Abstract][Full Text] [Related]
7. Mutations driving CLL and their evolution in progression and relapse.
Landau DA; Tausch E; Taylor-Weiner AN; Stewart C; Reiter JG; Bahlo J; Kluth S; Bozic I; Lawrence M; Böttcher S; Carter SL; Cibulskis K; Mertens D; Sougnez CL; Rosenberg M; Hess JM; Edelmann J; Kless S; Kneba M; Ritgen M; Fink A; Fischer K; Gabriel S; Lander ES; Nowak MA; Döhner H; Hallek M; Neuberg D; Getz G; Stilgenbauer S; Wu CJ
Nature; 2015 Oct; 526(7574):525-30. PubMed ID: 26466571
[TBL] [Abstract][Full Text] [Related]
8. Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia.
Landau DA; Clement K; Ziller MJ; Boyle P; Fan J; Gu H; Stevenson K; Sougnez C; Wang L; Li S; Kotliar D; Zhang W; Ghandi M; Garraway L; Fernandes SM; Livak KJ; Gabriel S; Gnirke A; Lander ES; Brown JR; Neuberg D; Kharchenko PV; Hacohen N; Getz G; Meissner A; Wu CJ
Cancer Cell; 2014 Dec; 26(6):813-825. PubMed ID: 25490447
[TBL] [Abstract][Full Text] [Related]
9. Regulatory B cells in anti-tumor immunity.
Zhang Y; Gallastegui N; Rosenblatt JD
Int Immunol; 2015 Oct; 27(10):521-30. PubMed ID: 25999597
[TBL] [Abstract][Full Text] [Related]
10. Clonal architecture of secondary acute myeloid leukemia defined by single-cell sequencing.
Hughes AE; Magrini V; Demeter R; Miller CA; Fulton R; Fulton LL; Eades WC; Elliott K; Heath S; Westervelt P; Ding L; Conrad DF; White BS; Shao J; Link DC; DiPersio JF; Mardis ER; Wilson RK; Ley TJ; Walter MJ; Graubert TA
PLoS Genet; 2014 Jul; 10(7):e1004462. PubMed ID: 25010716
[TBL] [Abstract][Full Text] [Related]
11. The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy.
Landau DA; Sun C; Rosebrock D; Herman SEM; Fein J; Sivina M; Underbayev C; Liu D; Hoellenriegel J; Ravichandran S; Farooqui MZH; Zhang W; Cibulskis C; Zviran A; Neuberg DS; Livitz D; Bozic I; Leshchiner I; Getz G; Burger JA; Wiestner A; Wu CJ
Nat Commun; 2017 Dec; 8(1):2185. PubMed ID: 29259203
[TBL] [Abstract][Full Text] [Related]
12. Tracking the Evolution of Non-Small-Cell Lung Cancer.
Jamal-Hanjani M; Wilson GA; McGranahan N; Birkbak NJ; Watkins TBK; Veeriah S; Shafi S; Johnson DH; Mitter R; Rosenthal R; Salm M; Horswell S; Escudero M; Matthews N; Rowan A; Chambers T; Moore DA; Turajlic S; Xu H; Lee SM; Forster MD; Ahmad T; Hiley CT; Abbosh C; Falzon M; Borg E; Marafioti T; Lawrence D; Hayward M; Kolvekar S; Panagiotopoulos N; Janes SM; Thakrar R; Ahmed A; Blackhall F; Summers Y; Shah R; Joseph L; Quinn AM; Crosbie PA; Naidu B; Middleton G; Langman G; Trotter S; Nicolson M; Remmen H; Kerr K; Chetty M; Gomersall L; Fennell DA; Nakas A; Rathinam S; Anand G; Khan S; Russell P; Ezhil V; Ismail B; Irvin-Sellers M; Prakash V; Lester JF; Kornaszewska M; Attanoos R; Adams H; Davies H; Dentro S; Taniere P; O'Sullivan B; Lowe HL; Hartley JA; Iles N; Bell H; Ngai Y; Shaw JA; Herrero J; Szallasi Z; Schwarz RF; Stewart A; Quezada SA; Le Quesne J; Van Loo P; Dive C; Hackshaw A; Swanton C;
N Engl J Med; 2017 Jun; 376(22):2109-2121. PubMed ID: 28445112
[TBL] [Abstract][Full Text] [Related]
13. Profiling of somatic mutations in acute myeloid leukemia with FLT3-ITD at diagnosis and relapse.
Garg M; Nagata Y; Kanojia D; Mayakonda A; Yoshida K; Haridas Keloth S; Zang ZJ; Okuno Y; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Ding LW; Alpermann T; Sun QY; Lin DC; Chien W; Madan V; Liu LZ; Tan KT; Sampath A; Venkatesan S; Inokuchi K; Wakita S; Yamaguchi H; Chng WJ; Kham SK; Yeoh AE; Sanada M; Schiller J; Kreuzer KA; Kornblau SM; Kantarjian HM; Haferlach T; Lill M; Kuo MC; Shih LY; Blau IW; Blau O; Yang H; Ogawa S; Koeffler HP
Blood; 2015 Nov; 126(22):2491-501. PubMed ID: 26438511
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal Instability as a Driver of Tumor Heterogeneity and Evolution.
Bakhoum SF; Landau DA
Cold Spring Harb Perspect Med; 2017 Jun; 7(6):. PubMed ID: 28213433
[TBL] [Abstract][Full Text] [Related]
15. Genetic and epigenetic determinants of B-cell lymphoma evolution.
Izzo F; Landau DA
Curr Opin Hematol; 2016 Jul; 23(4):392-401. PubMed ID: 27135978
[TBL] [Abstract][Full Text] [Related]
16. The oxygen fixation hypothesis: a reevaluation.
Ewing D
Am J Clin Oncol; 1998 Aug; 21(4):355-61. PubMed ID: 9708633
[TBL] [Abstract][Full Text] [Related]
17. Evolving understanding of the CLL genome.
Gruber M; Wu CJ
Semin Hematol; 2014 Jul; 51(3):177-87. PubMed ID: 25048782
[TBL] [Abstract][Full Text] [Related]
18. Recurrent mutations refine prognosis in chronic lymphocytic leukemia.
Baliakas P; Hadzidimitriou A; Sutton LA; Rossi D; Minga E; Villamor N; Larrayoz M; Kminkova J; Agathangelidis A; Davis Z; Tausch E; Stalika E; Kantorova B; Mansouri L; Scarfò L; Cortese D; Navrkalova V; Rose-Zerilli MJ; Smedby KE; Juliusson G; Anagnostopoulos A; Makris AM; Navarro A; Delgado J; Oscier D; Belessi C; Stilgenbauer S; Ghia P; Pospisilova S; Gaidano G; Campo E; Strefford JC; Stamatopoulos K; Rosenquist R;
Leukemia; 2015 Feb; 29(2):329-36. PubMed ID: 24943832
[TBL] [Abstract][Full Text] [Related]
19. Functional heterogeneity of genetically defined subclones in acute myeloid leukemia.
Klco JM; Spencer DH; Miller CA; Griffith M; Lamprecht TL; O'Laughlin M; Fronick C; Magrini V; Demeter RT; Fulton RS; Eades WC; Link DC; Graubert TA; Walter MJ; Mardis ER; Dipersio JF; Wilson RK; Ley TJ
Cancer Cell; 2014 Mar; 25(3):379-92. PubMed ID: 24613412
[TBL] [Abstract][Full Text] [Related]
20. Tumor Evolution as a Therapeutic Target.
Amirouchene-Angelozzi N; Swanton C; Bardelli A
Cancer Discov; 2017 Jul; ():. PubMed ID: 28729406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
